Text Size
13 studies found for:    GetGoal

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
GetGoal
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lixisenatide (AVE0010)
2 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo;   Device: insulin auto-injector
3 Not yet recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
4 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: placebo;   Drug: Pioglitazone;   Drug: Metformin
5 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Basal Insulin;   Drug: Metformin
6 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Sulfonylurea;   Drug: Metformin
7 Completed GLP-1 Agonist AVE0010 Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Exenatide;   Drug: Metformin
8 Completed GLP-1 Agonist AVE0010 (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Metformin
9 Completed 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo;   Drug: insulin glargine (HOE901);   Drug: metformin
10 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Metformin
11 Recruiting Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: insulin glulisine (HMR1964)
12 Completed GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Basal Insulin;   Drug: Sulfonylurea
13 Completed Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Metformin;   Drug: Sulfonylurea
To Top

† Indicates status has not been verified in more than two years